Market Research ReportDec 2, 2022

Autoinjectors Market

Autoinjectors Market Research Report: Size, Share, Trend Analysis Product Type (Disposable Autoinjectors, Standardized Autoinjectors), Therapeutic Application (Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Distribution Channel_Others) and By Region (Middle East and Africa, Americas, Asia Pacific, Europe) - Growth Outlook & Industry Forecast To 2024

Vertical: HealthcareBase Year: 2018

Book Demo

Executive Summary

Autoinjectors Market — Snapshot

Market Size (2018)
$30.78B
Projected (2024)
$79.74B
CAGR (2016–2024)
16.7%
Key Players
12+

Autoinjectors are medical devices used to deliver the drug of a dose. Most of the autoinjectors are spring loaded syringes. Growing aging patient population, the rise in demand for autoinjectors globally, and raising awareness regarding therapeutic diseases drive the growth of the global autoinjectors market. However, stringent regulatory policies may hamper the growth of the market.

The global autoinjectors market is expected to register a CAGR of 17.42% during the forecast period from 2019 to 2024. In 2018, the market was led by the Americas with 40.6% share, followed by Europe and Asia-Pacific with shares of 30.1% and 22.4%, respectively.

The global autoinjectors market has been segmented based on product type, design, therapeutic application, distribution channel, and region.

Based on product type, the disposable autoinjectors segment accounted for the largest market share of 65.7% in 2018, with a market value of USD 20,222.59 million, which is projected to register a CAGR of 17.90% during the forecast period.

Based on design, the customized autoinjectors segment accounted for the largest market share of 55.0% in 2018, with a market value of USD 16,931.25 million, which is projected to register a CAGR of 18.13% during the forecast period.

Based on therapeutic application, the anaphylaxis segment accounted for the largest market share of 35.0% in 2018, with a market value of USD 10,763.20 million, which is projected to register a CAGR of 17.80% during the forecast period.

Based on distribution channel, the retail pharmacies segment accounted for the largest market share of 55.7% in 2018, with a market value of USD 17,150.37 million, which is projected to register a CAGR of 17.74% during the forecast period.

Key Insight

The Autoinjectors Market market is projected to grow at a CAGR of 16.7% from 2016 to 2024.

Market Performance Trend

Historical performance and future projections (2020–2030, USD Billion)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Scope & Coverage

What this report covers

Geographic Coverage: This analysis covers 4 regions: Middle East and Africa, Americas, Asia Pacific, Europe.
Market Segmentation: The market is analyzed across 2 segments: Disposable Autoinjectors, Standardized Autoinjectors. Forecasts are provided for each segment from 2016 to 2024.
Competitive Landscape: 12 leading companies are profiled, covering market positioning, strategies, and recent developments.

Market Size (USD Mn)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Overview

Autoinjectors Market — Growth Trajectory

Autoinjectors are medical devices designed to deliver the dose of the drug. These are easy to use and are intended for self-administration by patients and physicians. These are often used in the military to protect personnel from chemical warfare agents. Autoinjectors have numerous advantages such as decreased needle phobia anxiety and maintain dose accuracy which in turn help in the growth of the market. The growing prevalence of targeted therapies, rising incidence of anaphylaxis, and the increasing number of regulatory approvals are factors responsible for market growth in this region.

Autoinjectors Market — Growth Trajectory

Disposable Autoinjectors

Standardized Autoinjectors

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Size Trend (USD Mn)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Dimensions

How this market is segmented

Product Type is analyzed as a distinct market dimension.
Therapeutic Application is analyzed as a distinct market dimension.
Distribution Channel is analyzed as a distinct market dimension.

Geographic Analysis

Regional market breakdown

Middle East and Africa market size reached $1.60B in 2016 and is projected to reach $5.54B by 2024, growing at a CAGR of 16.8%.
Americas market size reached $9.55B in 2016 and is projected to reach $31.03B by 2024, growing at a CAGR of 15.9%.

Asia Pacific market size reached $5.11B in 2016 and is projected to reach $18.86B by 2024, growing at a CAGR of 17.7%.
Europe market size reached $6.97B in 2016 and is projected to reach $24.31B by 2024, growing at a CAGR of 16.9%.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Research Methodology

Autoinjectors Market — How We Researched This Market

This report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.

Base Year
2018
Historical Period
2016 – 2017
Forecast Period
2019 – 2024
Primary Interviews
150+

Research Process

Historical data (2016–2018) and forecast period (2018–2024)

Problem Definition

Market scoping
Objective setting
Framework design

Secondary Research

Literature review
Data mining
Trend analysis

Primary Research

Expert interviews
Field visits
Surveys

Data Analysis

Quantitative modeling
Statistical testing
Validation

Insights & Reporting

Synthesis
Recommendations
Visualization

Research Depth

Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.

Historical vs. Forecast Data

Historical (observed)

Forecast (modelled)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Competitive Landscape & Porter's Five Forces

Autoinjectors Market — Competitive Analysis

The global autoinjectors market seems to be a very lucrative, attractive, and profitable market, both for existing as well as new entrants. At the same time, intense rivalry among existing competitors has been observed. Our analysis revealed that market players had adopted different strategies to increase their business and position in the global autoinjectors market. In recent years, strategic movements by major players were product launches, mergers and acquisitions, licensing agreement, collaboration/partnerships, establishment of subsidiary, and expansions, which have been used as market penetration strategies and to reduce competition. The major players in the global autoinjectors market are Amgen Inc., Becton, Dickinson and Company, Abbvie Inc., Mylan N.V., Eli Lilly and Company, Ypsomed, Owen Mumford Ltd, Consort Medical, SHL Group, Johnson & Johnson Services Inc., Teva Pharmaceutical Industries Ltd, Antares Pharma, and others.

There are numerous players operating in this market all over the globe. Most of these players exist in the American and European regions. There are a lot of large and small market players available in the market which provide a wide range of products for various applications. As there are many large and small players in the market, the market shares of these players are much differentiated. SHL Group, Mylan N.V., Abbvie Inc., Amgen Inc., and Eli Lilly and Company, are top players in the global autoinjectors market. Other prominent players are Becton, Dickinson and Company, Ypsomed, Antares Pharma, Inc., Consort Medical, Johnson & Johnson Services Inc.

Bargaining Power of Suppliers

Bargaining power of suppliers in the global autoinjectors market is medium. The suppliers in the global autoinjectors industry are medical device manufacturers. Currently, a moderate number of suppliers are present in the market due to stringent government regulations and high opportunities. Major players are accounting for a significant share of the market. Switching cost of the suppliers is medium because suppliers tend to enter into long-term associations, partnership, and deals with the companies that sell autoinjectors.

Bargaining Power of Buyers

The bargaining power of the buyers is medium in the global autoinjectors market due to the presence of many buyers of autoinjectors. The buyers of autoinjectors are moderately inclined towards product manufacturers. Moreover, the buyers can exert moderate pressure on the manufacturers as they already provide high-quality products and services. The market is captured by a limited number of players which indicates oligopoly in the market which leads to fewer options with regards to product offering thus the bargaining power of buyers tends to be medium in this market.

Threat of New Entrants

The threat of new entrants is low to medium in the global autoinjectors market. Any company trying to enter the autoinjectors market is required to accept the regulatory standards and product should get approval by regulatory authorities. This market is also characterized by a reasonable degree of brand loyalty where establishing a brand name is difficult for new entrants. Moreover, products which are already available in the market are patented, and the cost involved in R&D is high which creates unfavorable conditions for the new entrants in the market.

Threat of Substitutes

The threat of substitutes in the global autoinjectors market is medium to high. Substitutes pose a moderate to high threat in the global autoinjectors market due to the availability of similar products which are offered by major market players. However, the excellent product quality and brand loyalty of customers when it comes to emergency care products such as EpiPen (epinephrine autoinjectors) may restrict the threat by the substitutes to an extent. Also, the low-medium degree of switching cost may minimize the threat of substitutes.

Intensity of Rivalry

The degree of competition in the global autoinjectors market is high. Many manufacturers are present in the market. The market is shared by many major players, and their market share is fixed which indicates the high rivalry. Players are engaged in developing a process to lower their manufacturing cost to overcome the competition. Moreover, the players are also developing advanced techniques to differentiate their product from their rivals.

Quantitative Analysis

Regional Breakdown

Regional market breakdown for Autoinjectors Market.

Regional Market Size (USD Mn)

Market estimates by geography (2024)

USD Mn

InsightAmericas leads with $31.03B by 2024, while Asia Pacific is projected to grow fastest at a 17.7% CAGR.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Regional Market Data

REGION	2016	2018	2024	CAGR	SHARE
Middle East and Africa	$1.60B	$2.87B	$5.54B	16.8%	7%
Americas	$9.55B	$16.60B	$31.03B	15.9%	39%
Asia Pacific	$5.11B	$9.46B	$18.86B	17.7%	24%
Europe	$6.97B	$12.54B	$24.31B	16.9%	30%
Total	$23.23B	$41.48B	$79.74B	16.7%	100%

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Segment Revenue (2024)

Disposable Autoinjectors

Standardized Autoinjectors

015304560

Disposable Autoinjectors67%
Standardized Autoinjectors33%

Total Market Size

$79.74B

Market by Segment (2024)

APPLICATION	REVENUE ($B)	GROWTH RATE	MARKET PENETRATION
Disposable Autoinjectors	$53.70B	17.1%	67%
Standardized Autoinjectors	$26.04B	15.7%	33%

* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Empower your Business
with Insights

Save over 20% on
Annual Subscription

Subscribe now

Book a demo

See plans for professionals or small and medium businesses.

Analytics

Autoinjectors Market — Key Findings

Analytical insights on Autoinjectors Market covering market dynamics, competitive landscape, and strategic outlook.

Key Analytical Findings

The Autoinjectors Market market is projected to reach $79.74B by 2024, growing at 16.7% CAGR. The Disposable Autoinjectors segment holds the largest share.

Market Dynamics

The autoinjector is a medical device that is designed to deliver a dose of a drug. Autoinjectors are easy to use and are intended for self-administration by patients themselves or even by an untrained person. The site of injection depends on the drug-filled, but it is typically administered into the thigh or buttocks. The purpose behind designing these autoinjectors is to overcome the hesitation associated with self-administration of needle-based drug delivery devices. The 21st Century Care Act (CCA) offers the promise of low cost for medical devices, drugs, and combination products. Within the medical device, the autoinjector is positioned as a major contender with the potential to expand the target patient audience for many biotech therapies. Autoinjectors are most widely used in the military to protect personnel from chemical welfare agents. In the US military, atropine and 2-PAM-CL are used as a first aid against nerve agents. As there is a rising prevalence of multiple sclerosis and rheumatoid arthritis the demand for autoinjectors is increasing. The global autoinjectors market is expected to grow due to the rising incidence of anaphylaxis, the growing prevalence of targeted therapies, and an increasing number of regulatory approvals.

Market Drivers

Anaphylaxis is a sudden life-threating allergic reaction on the skin. The rising prevalence of anaphylaxis can be seen among children. As per a survey carried out by the McGill University Health Centre in 2016, around 6,00,000 Canadians were suffering from anaphylaxis. The study also showed that between 2011 and 2015, the annual percentage of emergency department (ED) visit to the MCH-MUHC due to anaphylaxis rose from 0.20% to 0.41%, with the largest annual increase between 2013 and 2014 and between 2014 and 2015. The majority (80.2%) of anaphylaxis cases were triggered by food, principally peanut, and tree nut, and that children who did not receive epinephrine prior to arrival at the ED were more likely to receive multiple doses of epinephrine at the hospital. As a rising incidence of anaphylaxis is observed, the demand for autoinjectors is also increasing. Overall there has been a net increase in the number of new and ongoing autoinjectors as compared to previous years, with the increasing use of autoinjectors. Hence, the demand for autoinjectors is expected to increase in the future.

Market Restraints

As some of the autoinjectors are not easily accessible, and there are a lot of complaints from the customers the FDA is issuing a warning for some of the EpiPen auto-injectors as well as for authorized generic versions of autoinjectors. The reason for product recall is also attributed to the defective parts in autoinjectors which may lead to false results. Hence, an increase in product recalls had been observed in recent years. The expanding recall of autoinjectors was seen not only in the US but also in other markets in North America and South America. In the US, around 13 lots of both EpiPen and EpiPen Jr. auto-injectors recall was observed on December 17, 2015, and July 1, 2016, respectively. Mylan, the company that markets autoinjector devices, announced in 2017 that they had recalled one lot of roughly 80,000 EpiPens autoinjectors from Australia, Europe, Japan, and New Zealand. As lots of manufacturing defects were found in autoinjectors, most of the products were recalled which eventually restrains the growth of the market.

Pricing Analysis

1.1 Pricing Analysis

As the trend towards globalization continues, more price transparency is expected along with the increasing professionalism of purchasing behavior. The cost of autoinjectors varies from market to market according to the need of customers. Manufacturers evaluate the market demand and production capacity in deciding the pricing for their products in a certain market.

In certain countries, the cost of autoinjectors is fixed, which in turn affects the pricing strategy of manufacturers and supply chain management who have to manage low costs and also not compromise on the quality of the materials produced.

While these companies may have a base, medium or high price, and quality levels, the price range cannot be easily identified as the product mix varies from country to country. Also, supplier incentive and demand encouragement can play a significant role in deciding the pricing of autoinjectors. In a fierce competing market, pharmaceutical companies will have to strategize their pricing levels as per the requirement and affordability of consumers to increase their market share.

Strategic Outlook and Future Directions

Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.

Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.

Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.

Market Value by Segment (2024)

Value (USD Mn)

Disposable Autoinjectors

Standardized Autoinjectors

Companies

Key companies profiled in Autoinjectors Market

Profiles of 104 companies operating in the Autoinjectors Market market, including revenue, employee count, and market positioning where available.

Region

Industry

Founded Year

Showing 104 of 104 companies

Antares Ph

Antares Pharma

Healthcare

Company Headquarters: New Jersey, US Founded: 1978 Workforce: 111 Company Working: Antares Pharma is a combination of drug-device companies focused primarily on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. The company develops, manufactures, and commercializes, novel therapeutic products using its advanced drug delivery systems that are designed to provide commercial or functional advantages, such as improved safety and efficacy, reduced side-effects, and enhanced patient comfort and adherence. Antares Pharma’s intramuscular and subcutaneous injection technology platforms include the Vibex and Vibex QuickShot pressure-assisted autoinjector systems suitable for branded and generic injectable drugs in unit dose containers as well as disposable multi-dose pen injectors. The company has a portfolio of proprietary and partnered commercial products and ongoing product development programs in various stages of development. It has formed significant strategic alliances and partnership arrangements with industry-leading pharmaceutical companies including Teva, Amag, and Pfizer.

Company Headquarters: Burgdorf, Switzerland Founded: 2003 Workforce: 1,604 Company Working: Ypsomed Holding AG (Ypsomed) develops, manufactures, and sells injection and infusion systems to pharmaceutical and biotechnology companies. The three business segments of the company include – Ypsomed Diabetes Care, Ypsomed Delivery Systems, and others. The company promotes and sells its products, directly to patients or through pharmacies and clinics under the umbrella brand, mylife Diabetes care. The company offers business-to-business (B2B) to pharmaceutical companies under Ypsomed Delivery Systems (YDS). Ypsomed operates in Switzerland, other European countries, North America, and internationally.

Burgdorf, Switzerland

Mylan N.V.

Healthcare

Company Overview Company Headquarters: Pennsylvania, US Founded: 1961 Workforce: 35,000+ Company Working: Mylan N.V. (Mylan) is a leading global pharmaceutical company. The company develops, licenses, manufactures, markets, and distributes generics, branded generics, brand name, and over-the-counter (OTC) products in a variety of dosage forms and therapeutic categories. Its global portfolio constitutes more than 7,500 marketed generic and branded generic brand names and OTC products around the world covering a vast array of therapeutic categories. Mylan’s team works in various offices and manufacturing facilities across the world. It has global centers in Bangalore, India; Canonsburg, Pennsylvania; and Dublin, Ireland. Its global research and development (R&D) centers are situated in Hyderabad, India, and Morgantown, West Virginia. It also has 12 technology-focused R&D sites across Europe, India, Japan, and the US. It adheres to the highest quality standards across its 50 manufacturing facilities worldwide

Consort Medical

Consort Medical — Healthcare

United States, North America

SHL Group

Healthcare

SHL Group — Healthcare

United States, North America

Owen Mumfo

Owen Mumford Ltd

Healthcare

Owen Mumford Ltd — Healthcare

United States, North America

Page 1 of 18

…

Go to page

About the Author

Healthcare Research Team

Healthcare

Our healthcare desk at Wantstats is staffed by a mix of clinical-market analysts and a senior researcher who track drug approvals, device launches, and provider economics as they happen — not just at reporting time. Every figure in this report is checked against primary interviews, regulatory filings, and our own proprietary datasets before it goes to print.

Similar Reports

View all

HealthcareJul 31, 2026

Stoma Ostomy Care Market

HealthcareJul 31, 2026

Ready-to-eat Popcorn Market

HealthcareJul 31, 2026

Organoids and Spheroids Market

Powering the world's best teams.
From next-gen startups to established enterprises.

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Autoinjectors Market

Autoinjectors Market Research Report: Size, Share, Trend Analysis Product Type (Disposable Autoinjectors, Standardized Autoinjectors), Therapeutic Application (Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Distribution Channel_Others) and By Region (Middle East and Africa, Americas, Asia Pacific, Europe) - Growth Outlook & Industry Forecast To 2024

Starting from

$4,950

Autoinjectors Market

Key Insight

Market Performance Trend

Market Scope & Coverage

What this report covers

Autoinjectors Market — Growth Trajectory

Market Size Trend (USD Mn)

Market Dimensions

How this market is segmented

Geographic Analysis

Regional market breakdown

Problem Definition

Secondary Research

Primary Research

Data Analysis

Insights & Reporting

Research Depth

Historical vs. Forecast Data

Competitive Landscape & Porter's Five Forces

Autoinjectors Market — Competitive Analysis

Regional Market Data

Segment Revenue (2024)

Segment Market Share

Market by Segment (2024)

Save over 20% onAnnual Subscription

Key Analytical Findings

Market Dynamics

Market Drivers

Market Restraints

Pricing Analysis

Strategic Outlook and Future Directions

Market Value by Segment (2024)

About the Author

Healthcare Research Team

Market Performance Trend

Autoinjectors Market — Growth Trajectory

Market Size Trend (USD Mn)

Market Dimensions

How this market is segmented

Geographic Analysis

Regional market breakdown

Problem Definition

Secondary Research

Primary Research

Data Analysis

Insights & Reporting

Research Depth

Historical vs. Forecast Data

Competitive Landscape & Porter's Five Forces

Autoinjectors Market — Competitive Analysis

Regional Market Data

Segment Revenue (2024)

Segment Market Share

Market by Segment (2024)

Save over 20% onAnnual Subscription

Key Analytical Findings

Market Dynamics

Market Drivers

Market Restraints

Pricing Analysis

Strategic Outlook and Future Directions

Market Value by Segment (2024)

About the Author

Healthcare Research Team

Save over 20% on
Annual Subscription

Save over 20% on
Annual Subscription